Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_assertion type Assertion NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_head.
- NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_assertion wasGeneratedBy ECO_0000203 NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_provenance.
- NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_assertion wasDerivedFrom befree-20150227 NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_provenance.
- NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_assertion SIO_000772 11927838 NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_provenance.
- NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_assertion evidence source_evidence_literature NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_provenance.
- NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_assertion description "[Statistically significant increases in asthma risk were also observed among the whole study population for the concurrent presence of the GSTM1 null genotype and either NAT1 (odds ratio [OR] 4.53, 95% CI 1.76 to 11.6) or NAT2 (OR 3.12, 95% CI 1.11 to 8.78) slow acetylator genotypes, and of NAT1 and NAT2 slow acetylator genotypes (OR 4.20, 95% CI 1.51 to 11.6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217285.RA5MDd9cbELh2qfvqnA6cV490agImUcremkgUISmioqt8130_provenance.